Features

News

Date	Description
8 May 2008	Intervet/Schering-Plough Animal Health appoints Executive Team Boxmeer, May 08, 2008 – Schering-Plough appointed the Executive Team members of the company’s global animal health unit: Intervet / Schering- Plough Animal Health. These appointments define the major ...
29 Apr 2008	Intervet/Schering-Plough Animal Health outlines strength of the combination First batch of bluetongue Bovilis BTV8 vaccine released to supply Northern European countriesBoxmeer, April 29, 2008 – Intervet/Schering-Plough Animal Health released the first batch of Bovilis BTV8 vaccine ...
17 Mar 2008	Prof. Dr. George Gettinby wins Dieter Luetticken Award Boxmeer, March 17, 2008 – Intervet’s Dieter Lϋtticken Award has been granted to Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom. Gettinby’s innovative statistical ...
29 Feb 2008	Intervet will supply French government with a minimum quantity of 27 million doses of Bluetongue vaccine Angers, February 29, 2008 – Today, Intervet received an official order of the Department for Agriculture and Fishery, France, to supply inactivated vaccine against Bluetongue, serotype 8.Intervet is working ...
27 Feb 2008	Intervet takes the lead in veterinary endocrinology at NAVC Orlando, February 27, 2008 – As part of its global program to encourage continuing education and research in the field of veterinary internal medicine, Intervet International, a part of Schering-Plough, ...
19 Jan 2008	Schering-Plough & Intervet together for better care Orlando, FL, U.S.A., January 19, 2008 –Throughout its history, Schering-Plough has focused on discovering and developing innovative new therapies in the human prescription, animal health and consumer ...
16 Jan 2008	Intervet has developed Bluetongue vaccine Boxmeer, January 16, 2008 – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and cattle. The vaccine ...
19 Nov 2007	Akzo Nobel completes OBS sale Intervet herewith publishes a press release by Akzo NobelAkzo Nobel completes OBS sale Amsterdam, the Netherlands, November 19, 2007 – Akzo Nobel N.V. has today completed the sale of Organon BioSciences ...
19 Nov 2007	Schering-Plough Completes Acquisition of Organon BioSciences Intervet herewith publishes a press release by Schering-PloughSchering-Plough Completes Acquisition of Organon BioSciencesCombination Expands Human Health Business, Creates a Global Leader in Animal Health ...
10 Nov 2007	Christmas donation for Afya Serengeti Every year, instead of traditional season’s greetings cards, Intervet supports charitable projects or organizations with activities that benefit animal welfare and people. This year Intervet’s Christmas ...
2 Nov 2007	Yearly Conference of Dairy Cattle Reproduction Council A second yearly convention of the US Dairy Cattle Reproduction Council took place in Denver, Colorado on 2nd -3rd November 2007. The Dairy Cattle Reproduction Council was formed as an organization gathering ...
24 Sep 2007	Lipoxen and Intervet Announce a Collaboration Agreement to Develop Sustained-Release Insulin Intervet herewith publishes a press release by Lipoxen Lipoxen PLC (“Lipoxen” or “the Company”) Lipoxen and Intervet, a leading Animal Health company, Announce a Collaboration Agreement to Develop ...
24 Aug 2007	Prof. Mark Stevens honored with Dieter Lütticken Award British scientist awarded for excellent contribution to the principle of 3Rs for the development and production of veterinary medicinal productsBoxmeer, August 24, 2007 – At the '6th World Congress on ...
29 Jun 2007	Intervet opens formulation and filling unit at its international competence center for Foot and Mouth Disease Today, Intervet, largest vaccine producer world wide, opens a new formulation and filling unit at the Foot and Mouth Disease (FMD) vaccine factory in Cologne, Germany. With this factory Intervet substantially ...
22 Jun 2007	Intervet Dieter Luetticken Award Intervet’s award to reduce the number of animals used in testing for development and production of animal veterinary medicinesIntervet offers the Dieter Lütticken award to promote scientists or life science ...
11 May 2007	Intervet's bird flu vaccine receives EU license Intervet, a leading animal health company, received approval for its bird flu (avian influenza) vaccine Nobilis® Influenza H7N1. As a result, Europe now has a licensed vaccine to protect birds against ...
3 May 2007	Dieter Luetticken Award Winner The annual Dieter Lütticken Award, has been granted to Dr Mark Stevens from the Institute of Animal Health, United Kingdom for his commitment to advancing the 3R concept – reducing, refining or replacing ...
12 Mar 2007	Akzo Nobel announces Intended Sale of Organon Biosciences to Schering-Plough for EUR 11 billion Akzo Nobel is pleased to announce that on March 11, 2007, it received an offer for the purchase of its wholly owned subsidiary Organon BioSciences N.V. (OBS) from Schering-Plough for EUR 11 billion in ...
26 Feb 2007	Akzo Nobel confirms IPO timing of Organon Biosciences For more information check the Akzo Nobel website: http://www.akzonobel.com/com/News/News.htm?itemid=f14e3b3a-9dd9-4819-b181-701fcb6ae520
15 Feb 2007	Akzo Nobel Annual Results 2006: Record year Operational highlights • Revenues up 6% – growth in all segments • Record net income of EUR 1.15 billion – up 20% • Operational results up 14% • Incidentals positive contribution ...
29 Jan 2007	Intervet opens new production facility for vaccines Intervet, the world’s largest producer of vaccines for animals, will open a production facility for vaccines in Boxmeer, the Netherlands, today. This will strengthen Boxmeer’s position as Intervet’s largest ...
25 Jan 2007	Akzo Nobel reconfirms listing of Organon Biosciences Akzo Nobel has previously announced its intention to separate its Pharma business, preferably through a listing of approximately 20 to 30 percent of Organon BioSciences shares on Euronext in Amsterdam ...
15 Nov 2006	Intervet appoints Jochen Bader Vice President Finance and Control Intervet, the animal health business unit of Akzo Nobel, appointed the current Director Finance and Control, Jochen Bader (46), Vice President Finance and Control. After graduating from ‘Fachhochschule’ ...
15 Nov 2006	Intervet appoints Malte Greune as a member of the company's Executive Committee Intervet, Akzo Nobel’s veterinary pharma business, announces that Malte Greune (41) has been appointed as a member of Intervet’s Executive Committee. Malte Greune will succeed Joost Helsen in the function ...
4 Oct 2006	Intervet appoints Ellen de Brabander as a member of the company’s Executive Committee Intervet, Akzo Nobel’s veterinary pharma business, announces that Ellen de Brabander – van den Berg (43) has been appointed as a member of Intervet’s Executive Committee, effective October 1, 2006. Ellen ...
14 Sep 2006	Intervet’s equine West Nile vaccine approved by USDA An equine vaccine developed by Akzo Nobel’s animal health business Intervet, which is indicated for use in horses at risk from West Nile virus has been approved by the United States Department of Agriculture ...
1 Sep 2006	Intervet’s avian flu vaccine licensed for use in European Union Intervet’s vaccine is based on a different strain (H5N2) than the current field strain (H5N1). Birds vaccinated with H5N2 form a different set of antibodies than those birds infected with H5N1. These ...
21 Aug 2006	Intervet Receives FDA Approval for Zilmax Intervet’s U.S. business (Intervet Inc.) has received approval from the U.S. Food and Drug Administration (FDA) for Zilmax (zilpaterol hydrochloride), a product designed to improve production efficiencies ...
27 Jul 2006	Intervet continues to invest in Saxe Gotha business park in Boxmeer On 27 July 2006, Intervet purchased the Plukon site at Saxe Gotha business park in Boxmeer. Covering over four hectares, the site is located opposite Intervet’s facilities. Thanks to this purchase, Intervet ...
5 Jul 2006	Foot-and-Mouth disease vaccine factory now owned by Intervet Five months after signing an agreement on sale and purchase the Foot-and-Mouth (FMD) vaccine factory in Cologne Bayer HealthCare AG and Intervet International bv have completed the acquisition. Both ...
12 Jun 2006	Intervet develops prototype for mass application avian influenza vaccine A biotech breakthrough achieved by Akzo Nobel’s animal health business, Intervet, means that mass application of a dual vaccine against avian influenza and Newcastle Disease could be available in the ...
29 May 2006	Intervet Dieter Lütticken Award - Intervet’s award to reduce the number of animals used in testing for development and production of animal veterinary medicines Intervet International bv offers the Dieter Lütticken award to promote scientists or life science research institutions working in research areas that serve the 3R-concept i.e. reducing, refining or replacing ...
27 Apr 2006	Intervet supplies German zoos with avian influenza vaccine On initiative of several federal states, Germany has obtained the European Union’s permission to vaccinate birds in zoos against avian influenza. To show its commitment to the preservation and protection ...
21 Apr 2006	DSM Nutritional Products buys CRINA feed additive business from Intervet International Intervet herewith publishes a press release by DSM.Kaiseraugst (CH), 21st April 2006 Intervet International and DSM Nutritional Products signed an agreement on sale and purchase of the CRINA business. ...
27 Mar 2006	Akzo Nobel Pharma preparing for the future Arnhem, the Netherlands, March 27, 2006 — Akzo Nobel’s Pharma group is aiming to deliver at least one major filing per year from its pipeline as it positions itself for solid growth. Speaking at today’s ...
1 Mar 2006	Frequently asked questions with regard to the Avian flu, answered by Intervet International, March 1, 2006 Update of FAQ of 22-02-2006Statement to decision taken by the European Commission:Intervet welcomes the decision of the European Commission of February 22, 2006, to approve the vaccination plans against ...
22 Feb 2006	Frequently asked questions with regard to the Avian flu, answered by Intervet International, February 22, 2006 Statement to decision taken by the European Commission:Intervet welcomes the decision of the European Commission of February 22, 2006, to approve the vaccination plans against bird flu of the French and ...
16 Feb 2006	Intervet supplies Avian Influenza vaccine to French Government Yesterday the French Ministry of Agriculture announced the intention to vaccinate outdoor ducks against Avian Influenza in three western parts of France (Landes, Loire atlantique and Vendée). The French ...
10 Feb 2006	Intervet International bv acquires Foot and Mouth Disease vaccine factory from Bayer HealthCare AG Boxmeer, February 10, 2006 – Today, Intervet, the animal health business unit of Akzo Nobel, announced the agreement with Bayer HealthCare AG to acquire the Foot and Mouth Disease (FMD) vaccine factory ...
7 Feb 2006	Akzo Nobel 2005 net income improves as effective strategy drives revenue growth Main highlights Net income up at EUR 961 million Growth in all units—revenues from present operations up 6% Organon—returning to growth, investing in future product sales and pipeline Intervet—excellent ...
7 Feb 2006	Strategic initiatives deliver strong growth and basis for new platform Organon Biosciences Boxmeer, the Netherlands, February 7, 2006 – Akzo Nobel NV has announced today that it intends to separate its pharmaceutical activities from its chemicals and coatings businesses. The aim is to create ...
20 Dec 2005	Millions to benefit from Intervet project in India Arnhem, the Netherlands, December 19, 2005 – Akzo Nobel’s animal healthcare business, Intervet, has signed a Memorandum of Understanding to exclusively supply veterinary products for a special project ...
21 Nov 2005	Intervet to support European Zoos Boxmeer, 21 November 2005 - In October the European Commission published a decision permitting the vaccination of zoo birds against bird flu, under certain conditions. The Dutch Government received EU ...
18 Oct 2005	Akzo Nobel developing human H5N1 vaccine Arnhem / Boxmeer, the Netherlands, October 18, 2005 - Akzo Nobel’s Nobilon International business, which is active in the field of biotechnology, is developing a human vaccine against the deadly H5N1 ...
29 Sep 2005	Dutch Ministry signed contract on vaccine bank for Classical Swine Fever On 28th of September 2005 the Dutch Ministry of Agriculture signed a contract with Intervet about a vaccine bank of Porcilis Pesti, Intervet's marker vaccine against Classical Swine Fever. The agreement ...
22 Aug 2005	Swiss scientist honored for excellent contribution to the principles of 3R's August 22, 2005 – At the '5th World Congress on Alternatives', on 22 August in Berlin, Germany Prof. Andrew Hemphill, University of Bern, Switzerland was honored with the Intervet Dieter Lütticken Award ...
9 Aug 2005	Agreement reached for Intervet to acquire AgVax Developments Ltd, New Zealand Boxmeer, the Netherlands, and Hamilton, NZ, August 9, 2005 - Intervet aims to extend its market presence in New Zealand with the acquisition of AgVax Developments Ltd., a highly successful animal health ...
7 Jun 2005	Intervet to divest part of feed additives business Akzo Nobel Press ReleaseIntervet to divest part of feed additives business Arnhem, the Netherlands, June 7, 2005 – Akzo Nobel’s animal healthcare business, Intervet, has agreed to divest some of its ...
2 May 2005	Announcement of new selection round Dieter Lütticken Award Intervet Dieter Lütticken Award Intervet’s annual award to reduce the number of animals used in testing for development and production of animal veterinary medicinesBoxmeer, May 2005 – For the second ...
2 May 2005	Announcement of winner Dieter Lütticken Award Intervet Dieter Lütticken Award New annual prize to reduce the number of testing animals in veterinary medicines awarded to Prof. Andrew Hemphill, SwitzerlandBoxmeer, May 2005 – For the first time Intervet ...
4 Feb 2005	Success through focus - Intervet sales release Boxmeer, February 4, 2005 - With net sales of EUR 1,024 million Intervet met its targets for 2004, consolidating its position as one of the world's three biggest animal health companies. Sales as reported ...
1 Dec 2004	IDEXX Laboratories acquires Bommeli Diagnostics [Trade] Intervet herewith publishes a press release by IDEXX Laboratories Inc. acquiring Dr. Bommeli AG, an Intervet company.WESTBROOK, Maine, December 1, 2004—IDEXX Laboratories, Inc. (NASDAQ: IDXX), announced ...
23 Aug 2004	IDEXX Laboratories to purchase Bommeli Diagnostics Intervet herewith publishes a press release by IDEXX Laboratories Inc. purchasing Dr. Bommeli AG, an Intervet company.WESTBROOK, Maine, TBD, 2004-08-23—The Production Animal Services group of IDEXX Laboratories, ...
21 Jun 2004	Intervet India Commended For Its Commitment Boxmeer, the Netherlands, June 18, 2004 – Last week, Intervet India received the Holland Award for its 'outstanding achievements in the field of International Agri-business in India and the Animal Health ...
3 May 2004	Feed Additives Business transferred to Intervet Boxmeer/Stenungsund, May 3, 2004 - In order to provide better market alignment and to strengthen Akzo Nobel’s overall position in feed additives, Akzo Nobel has decided to consolidate the CRINA® and Bredol ...
19 Feb 2004	Intervet maintains course despite economic headwinds Boxmeer, Netherlands, February 19, 2004 – With total sales in 2003 of EUR 1,010 million, Intervet is well positioned to maintain its No. 3 position in the global animal health market despite the economic ...
2 Feb 2004	Intervet provides support to authorities' efforts to halt the spread of bird flu in Asia Boxmeer, the Netherlands, February 2, 2004 – Intervet, Akzo Nobel’s animal healthcare business, is providing local and international authorities support to combat the avian flu (Avian Influenza) epidemic ...
8 Dec 2003	All tools for emergency vaccination against Classical Swine Fever available after EU positively evaluates discriminatory antibody test Boxmeer, December 05, 2003 At the beginning of this month, the EU Standing Committee approved the EU Commission Decision on the positive evaluation of a discriminatory test for Classical Swine Fever (CSF). ...
2 Dec 2003	Akzo Nobel opens new biotech vaccines facility Arnhem, the Netherlands, December 1, 2003 - Akzo Nobel officially opened its new biotech vaccines production facility in Boxmeer this afternoon. The opening ceremony was performed by Secretary-General ...
31 Oct 2003	Nobilis Salenvac T vaccine receives award at VIV Europe 2003 Boxmeer, October 19, 2003 - Nobilis Salenvac T, Intervet’s new vaccine that provides excellent protection for breeder and layer birds against Salmonella infections has received the VIV award in the category ...
23 Oct 2003	Salenvac T vaccine spreads wings at VIV Boxmeer, September 1, 2003 - VIV 2003 is the first non-UK debut of Nobilis Salenvac T, Intervet’s salmonella vaccine that protects against both S.enteritidis and S.typhimurium, making it an important ...
17 Oct 2003	Akzo Nobel earnings in line with expectations, outlook unchanged Arnhem, the Netherlands, October 17, 2003 – Akzo Nobel, the international pharmaceuticals, coatings and chemicals company, reports third quarter net earnings of EUR 178 million, 23% below the third quarter ...
20 May 2003	Intervet donates flu vaccine Hundreds of tropical birds in the Netherlands have been vaccinated against Avian influenza with the help of Akzo Nobel’s animal healthcare business, Intervet. An outbreak of the disease struck a number ...
11 Apr 2003	Bommeli Diagnostics launches New CHEKIT-APP-AppIV Test Liebefeld-Bern, Switzerland -March 15, 2003- Bommeli Diagnostics, the diagnostic unit within Akzo Nobels veterinary business Intervet International bv today announced the launch of its new and improved ...
1 Apr 2003	Vaccination against Avian Influenza Boxmeer, March 27, 2003 - The outbreak of Avian Influenza (fowl plague) in the Netherlands has sparked an ongoing debate about vaccination as an additional measure to control this viral disease. In principle, ...
13 Mar 2003	Intervet weathered market challenges in 2002 Boxmeer, March 07, 2003 – Intervet’s excellent global coverage and its broad range of products for farm and companion animals put the company in a stable position to weather the year’s dips in the veterinary ...
11 Mar 2003	Akzo Nobel earnings slightly down; debt reduced by EUR 800 million Arnhem, the Netherlands, February 11, 2003 – Akzo Nobel, the international pharmaceuticals, coatings and chemicals company, reports net earnings (1) in line with the outlook of EUR 892 million, slightly ...
11 Mar 2003	Background information on Avian Influenza outbreak General background informationBoxmeer, March 11, 2003 – On March 1, 2003, the Dutch government decided to place a ban on all transport and export of poultry and poultry related farming products following ...
6 Nov 2002	Akzo Nobel’s Pharma proactive on growth Akzo Nobel’s Pharma businesses are taking active steps to turn around a current temporary slowing in performance and return to a path of stable growth in the future. Akzo Nobel’s Pharma group will continue ...
23 Oct 2002	Akzo Nobel 2002 third quarter net income 3% down; outlook confirmed Akzo Nobel, the international pharmaceutical, coatings and chemicals company, today announced a third quarter net income of EUR 232 million, 3% below last year. The outlook for 2002 was confirmed.Highlights:· All ...
21 Apr 2002	Mycofarm Nederland bv fully integrated into Intervet Nederland BV Mycofarm Nederland bv fully integrated into Intervet Nederland bvBoxmeer, 19 April 2002 – Mycofarm Nederland bv and Intervet Nederland bv, the two Dutch subsidiaries of Intervet International bv, will ...
21 Mar 2002	Intervet closes 2001 in excellent shape In 2001, Intervet placed a stronger focus on strengthening its presence in key country markets, notably the United States. With approximately 46 percent of the sales, Europe, the home market of Intervet, ...
22 Feb 2002	Resilient mix of businesses protects Akzo Nobel earnings The net result1 for the fourth quarter exceeded the previous year’s figure by 3%. Pharma’s and Coatings’ ongoing operations closed higher. Pharma especially benefited from higher sales, while for Coatings ...
21 Nov 2001	Award of ‘Pettenkofer-Foundation’ presented to Dr. Teshome Mebatsion Mid of November Dr. Teshome Mebatsion of Intervet International, Virology R&D received in Munich the Pettenkofer Prize 2001.This prize is presented every two years to scientists who perform outstanding ...
11 Oct 2001	Product news FMD Marker Intervet announces FMD marker test Intervet, Akzo Nobel’s animal healthcare business, has developed a test for Foot and Mouth Disease (FMD) to indicate virus infection in vaccinated animals. The ...
21 Mar 2001	Akzo Nobel appoints new manager for its business unit Intervet Ruurd Stolp, who holds a PhD in Veterinary Medicine from University of Utrecht, joined Intervet in 1989 as Head, Microbiological Quality Control. Following his return in 1996 from a post with Intervet’s ...